Evidence map›Paper›PMID 24606759›Full record

ReviewExpert reviews in molecular medicine2014

Histo-blood group antigens: a common niche for norovirus and rotavirus.

Ming Tan, Xi Jiang

Open access · greenAbstract readReview
In one paragraph

Review in Expert reviews in molecular medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 107 papers.

0numbers the graph read from it
0cells of the map it votes in
107citing papers in PubMed
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

107 citing papers in PubMed, 156 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Molecular genetic characterisation of norovirus GII.17 strains circulating in South Korea in 2024.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  5. Host Glycan-Lectin Interplay in SARS-CoV-2 Infection.International journal of molecular sciences · 2026
    Review
  6. Article
  7. Review
  8. Article
  9. Gut microbes · 2025
    Article
  10. Article
  11. Diverse processes in rotavirus vaccine development.Human vaccines & immunotherapeutics · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Species-SpecificMarine drugs · 2023
    Article

47 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ming TanCincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Xi JiangCincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Cincinnati Children's Hospital Medical Center · US

Funding

VIRAL GASTROENTERITIS PATHOGENSP01HD013021 · NICHD · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MORROW, ARDYTHE L · 1985 to 2013
$15.0M
Cincinnati Center for Clinical and Translational Sciences and TrainingUL1TR000077 · NCATS · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E. · 2012 to 2014
$9.9M
Novel vaccine against NorovirusR01AI089634 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI JIANG, XI · 2010 to 2014
$4.7M
Characterization of Human CalicivirusesR01AI037093 · NIAID · EASTERN VIRGINIA MEDICAL SCHOOL · PI JIANG, XI · 1997 to 2010
$2.8M
Norwalk-like Viruses and Their ReceptorsR01AI055649 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI JIANG, XI · 2005 to 2009
$1.4M
Norovirus P Particle, A Multifunctional Platform For Vaccine DevelopmentR21AI092434 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI TAN, MING · 2011 to 2012
$421k
NCATS NIH HHS 8UL1TR000077-04NCATS NIH HHS UL1 TR000077NIAID NIH HHS R01 AI037093NIAID NIH HHS R01 AI055649NIAID NIH HHS R01AI055649NIAID NIH HHS R01 AI089634NIAID NIH HHS R01AI089634NIAID NIH HHS R01AI37093NIAID NIH HHS R21 AI092434NIAID NIH HHS R21AI092434NICHD NIH HHS P01 HD013021NICHD NIH HHS P01 HD13021
6 · The paper itself

Abstract

Noroviruses (NoVs) and rotaviruses (RVs), the two most important causes of viral acute gastroenteritis, are found to recognise histo-blood group antigens (HBGAs) as receptors or ligands for attachment. Human HBGAs are highly polymorphic containing ABO, secretor and Lewis antigens. In addition, both NoVs and RVs are highly diverse in how they recognise these HBGAs. Structural analysis of the HBGA-binding interfaces of NoVs revealed a conserved central binding pocket (CBP) interacting with a common major binding saccharide (MaBS) of HBGAs and a variable surrounding region interacting with additional minor binding saccharides. The conserved CBP indicates a strong selection of NoVs by the host HBGAs, whereas the variable surrounding region explains the diverse recognition patterns of different HBGAs by NoVs and RVs as functional adaptations of the viruses to human HBGAs. Diverse recognition of HBGAs has also been found in bacterial pathogen Helicobacter pylori. Thus, exploratory research into whether such diverse recognitions also occur for other viral and bacterial pathogens that recognise HBGAs is warranted.

Indexed as

Virus AttachmentAnimalsBlood Group AntigensCaliciviridae InfectionsEvolution, MolecularGastroenteritisHost-Pathogen InteractionsHumansNorovirusPolymorphism, GeneticRotavirusRotavirus InfectionsBlood Group Antigens

Identifiers

PMID24606759
PMCPMC12406300
OpenAlexW2105926019

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.